Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
30,210,911
-
Number of holders
-
20
-
Total 13F shares, excl. options
-
2,976,441
-
Shares change
-
-515,633
-
Total reported value, excl. options
-
$19,019,006
-
Value change
-
-$5,819,346
-
Number of buys
-
10
-
Number of sells
-
26
-
Price
-
$6.39
Institutional Holders of Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) as of Q2 2017
As of 30 Jun 2017 Fulgent Genetics, Inc. - Common Stock, par value $0.0001 per share (FLGT) had 40 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,976,441 shares of stock of the company.
Largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, Cormorant Asset Management, LLC, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, SCHOLTZ & COMPANY, LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, GRANAHAN INVESTMENT MANAGEMENT INC/MA, BLAIR WILLIAM & CO/IL, ELEMENT CAPITAL MANAGEMENT LLC, and BlackRock Inc..
This table shows 40 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.